An integrated crisis communication framework for strategic crisis communication with the media: A case study on a financial services provider

In order for organisations to survive in an ever-changing milieu in the current business environment, sufficient crisis communication and management practices need to be in place to ensure organisational survival. Despite the latter, organisational crises are often inefficiently managed which could be ascribed to the lack of managing crises strategically (Kash & Darling 1998:180). This article explores the lack of strategic crisis communication processes to ensure effective crisis communication with the media as stakeholder group. It is argued that the media is one of the main influences of public opinion (Pollard & Hotho 2006:725), thereby emphasising the need for accurate distribution of information. Furthermore, the study will focus specifically on the financial industry, as it is believed that this industry is more sensitive and thus more prone towards media reporting as financial services providers manage people’s money (Squier 2009). A strategic crisis communication process with the media is therefore proposed, facilitated through an integrated crisis communication framework, which focuses on a combination of Integrated Communication (IC) literature with emphasis on Grunig’s theory of communication excellence to build sustainable media relationships through two-way communication; and proposing a crisis communication process that has proactive, reactive and post-evaluative crisis communication stages, thereby moving away from crisis communication as a predominant reactive function.Communication Scienc

Effect of allopurinol in addition to hypothermia treatment in neonates for hypoxic-ischemic brain injury on neurocognitive outcome (ALBINO): Study protocol of a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III)

Background: Perinatal asphyxia and resulting hypoxic-ischemic encephalopathy is a major cause of death and long-term disability in term born neonates. Up to 20,000 infants each year are affected by HIE in Europe and even more in regions with lower level of perinatal care. The only established therapy to improve outcome in these infants is therapeutic hypothermia. Allopurinol is a xanthine oxidase inhibitor that reduces the production of oxygen radicals as superoxide, which contributes to secondary energy failure and apoptosis in neurons and glial cells after reperfusion of hypoxic brain tissue and may further improve outcome if administered in addition to therapeutic hypothermia. Methods: This study on the effects of ALlopurinol in addition to hypothermia treatment for hypoxic-ischemic Brain Injury on Neurocognitive Outcome (ALBINO), is a European double-blinded randomized placebo-controlled parallel group multicenter trial (Phase III) to evaluate the effect of postnatal allopurinol administered in addition to standard of care (including therapeutic hypothermia if indicated) on the incidence of death and severe neurodevelopmental impairment at 24 months of age in newborns with perinatal hypoxic-ischemic insult and signs of potentially evolving encephalopathy. Allopurinol or placebo will be given in addition to therapeutic hypothermia (where indicated) to infants with a gestational age 65 36 weeks and a birth weight 65 2500 g, with severe perinatal asphyxia and potentially evolving encephalopathy. The primary endpoint of this study will be death or severe neurodevelopmental impairment versus survival without severe neurodevelopmental impairment at the age of two years. Effects on brain injury by magnetic resonance imaging and cerebral ultrasound, electric brain activity, concentrations of peroxidation products and S100B, will also be studied along with effects on heart function and pharmacokinetics of allopurinol after iv-infusion. Discussion: This trial will provide data to assess the efficacy and safety of early postnatal allopurinol in term infants with evolving hypoxic-ischemic encephalopathy. If proven efficacious and safe, allopurinol could become part of a neuroprotective pharmacological treatment strategy in addition to therapeutic hypothermia in children with perinatal asphyxia. Trial registration: NCT03162653, www.ClinicalTrials.gov, May 22, 2017

Cratering behaviour and faecal C:N ratio in relation to seasonal snowpack characteristics in a High-Arctic ungulate

Snow and ice determine winter forage availability for Arctic herbivores. Winter precipitation is anticipated to increase, and icing following warm spells and rain-on-snow (ROS) are likely to become more frequent. While this may reduce herbivore survival, fecundity and population growth, we can also expect behavioural and dietary responses. Here, we tested predictions from optimal foraging theory on how changing snowpack conditions influence choice of feeding craters and diet quality in a large generalist herbivore, the wild Svalbard reindeer. Snow and ice conditions over winter 2012/13 (a ‘normal’ winter with little ROS and icing) were measured in reindeer feeding craters, in paired controls one metre away and in fixed control sites. On average, feeding craters had less snow and integrated ram hardness (IRH, the force needed to reach the ground), but not less ice, than nearby controls. However, on this fine spatial scale, reindeer tended to select for microhabitat with worse snowpack conditions up to a certain level of snow (ca. 10 cm), ice (0.5 cm) and IRH (250 kg cm) in the nearby controls, reflecting the trade-off between selection for forage abundance versus accessibility in a sparsely vegetated environment. In this lichen-free system, faecal C:N ratios increased during winter as forage accessibility was increasingly restricted by snow, possibly indicating a reduction in diet quality due to changes in diet composition. Our study suggests that snowpack depth and hardness largely determine Svalbard reindeer feeding behaviour and diet quality during the course of a winter season